Context-Dependent Binding by the MYC Oncoprotein: The Cellular Basis for Sustainable Tumor Regression
CSEF · 2004 Biochemistry/ Molecular Biology
Overview
Objectives/Goals Research has shown that even temporary inactivation of the oncogene c-MYC can induce osteosarcoma tumors to regress. Surprisingly, when MYC is reactivated in these differentiated cells, the oncogene lacks the ability to reinduce tumorigenesis. Once this phenomenon is better understood, oncogene inactivation will hold much promise in the clinic. The hypothesis tested here is that the MYC oncoprotein, a transcription factor, binds to target loci differently upon reactivation, depending on cellular context (differentiated or cancerous state), which produces the behavioral change in response to MYC. Methods/Materials Murine cancer cell lines containing a conditionally regulated MYC transgene were compared across three conditions: #MYC-activated# (MYC on for 48 hours; cancerous); #MYC-inactivated# (MYC off 48 hours; differentiated); and #MYC-reactivated# (MYC off 48, then on 20 hours; differentiated). Results First, a cDNA microarray assay showed global changes in gene expression. Genes were selected for further study by a short, custom-written Perl program that searched for MYC binding loci in promoter regions, as well as confirmation of microarray results by RT-PCR. A chromatin immunoprecipitation (ChIP) assay showed up to 5-fold changes in the binding of MYC to target loci. Conclusions/Discussion The results suggest that MYC#s inability to reinduce tumorigenesis may stem from compromised regulation of target genes, which in turn may come from a change in MYC#s binding to target loci. Therefore, cellular context affects a cell#s vulnerability to the oncogene through binding and regulation of target genes. Future work will identify factors that affect MYC#s binding and bring oncogene inactivation therapy one step closer to the clinic.
Summary statement
Oncogene inactivation leads to sustained tumor regression because upon reactivation the oncoprotein binds to target genes differently.
Help received
Used lab equipment at Stanford University in lab of Dr. Dean Felsher, under the supervision of Dr. Natalie Wu; began project as a summer intern under the Center for Clinincal Immunology at Stanford Summer Internship program
Awards (1)
- Category Award
Competition history
- CSEF 2004
Resources
Related projects
ISEF · 2023
Development of Selective MIZ-1 BTB Domain Inhibitors Targeting HUWE1 E3 Ligase in MYC-Driven Cancers
ISEF · 2025
Targeting Cap-Independent Translation in c-MYC mRNA: A Novel Small Molecule Approach for Cancer Therapy
ISEF · 2015
The Effect of Small Molecule Activators of PP2A (SMAPs) on N-Myc Driven Neuroblastomas
CSEF · 2018
Illuminating Gene Dysregulation in Cancer: Deep Learning Identification of Disrupted Transcription Factor Binding Sites
ISEF · 2024
Grand Theft Transcription Factor: Reversing Tumor Cell Immortality by Transcription Factor Relocalization
CSEF · 2023
Novel Strategies for the Reversal of Cancer Cell Immortality
AJAS · 2026
Grand Theft Transcription Factor: Reversing Tumor Cell Immortality by Relocalization
CSEF · 2013
The Effect of Cancer Stem Cells and the Tumor Microenvironment on Tumor Growth and Invasion
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects